JP2023524596A5 - - Google Patents
Info
- Publication number
- JP2023524596A5 JP2023524596A5 JP2022567836A JP2022567836A JP2023524596A5 JP 2023524596 A5 JP2023524596 A5 JP 2023524596A5 JP 2022567836 A JP2022567836 A JP 2022567836A JP 2022567836 A JP2022567836 A JP 2022567836A JP 2023524596 A5 JP2023524596 A5 JP 2023524596A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- independently
- alkyl
- case
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025145822A JP2026004302A (ja) | 2020-05-08 | 2025-09-03 | Akt3モジュレーター |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063021727P | 2020-05-08 | 2020-05-08 | |
| US63/021,727 | 2020-05-08 | ||
| US202063121077P | 2020-12-03 | 2020-12-03 | |
| US63/121,077 | 2020-12-03 | ||
| PCT/US2021/031386 WO2021226519A1 (en) | 2020-05-08 | 2021-05-07 | Akt3 modulators |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025145822A Division JP2026004302A (ja) | 2020-05-08 | 2025-09-03 | Akt3モジュレーター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524596A JP2023524596A (ja) | 2023-06-12 |
| JP2023524596A5 true JP2023524596A5 (cg-RX-API-DMAC10.html) | 2024-05-16 |
| JP7739334B2 JP7739334B2 (ja) | 2025-09-16 |
Family
ID=78468505
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567836A Active JP7739334B2 (ja) | 2020-05-08 | 2021-05-07 | Akt3モジュレーター |
| JP2025145822A Pending JP2026004302A (ja) | 2020-05-08 | 2025-09-03 | Akt3モジュレーター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025145822A Pending JP2026004302A (ja) | 2020-05-08 | 2025-09-03 | Akt3モジュレーター |
Country Status (12)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021212111A1 (en) * | 2020-04-17 | 2021-10-21 | Augusta University Research Institute, Inc. | Compositions and methods for treating leukemia |
| CN116217320B (zh) * | 2023-03-02 | 2025-03-04 | 哈尔滨工业大学(深圳) | 一种非均相催化炔烃与叠氮的轴手性Click合成方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US20030225273A1 (en) * | 2002-03-21 | 2003-12-04 | Michaelides Michael R. | Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| US7534423B2 (en) | 2003-03-28 | 2009-05-19 | Faron Pharmaceuticals Oy | Method for inducing an elevated level of adenosine in an individual |
| EP2078008A2 (en) * | 2006-10-12 | 2009-07-15 | SuperGen, Inc. | Quinoline derivatives for modulating dna methylation |
| CA2678180A1 (en) | 2007-02-13 | 2008-12-04 | Northeastern University | Methods and compositions for improving immune responses |
| US7939546B2 (en) * | 2007-10-12 | 2011-05-10 | Supergen, Inc. | Quinoline derivatives for modulating DNA methylation |
| US7790746B2 (en) * | 2007-10-12 | 2010-09-07 | Supergen, Inc. | Quinoline derivatives for modulating DNA methylation |
| FR2972535B1 (fr) * | 2011-03-07 | 2014-05-02 | Crime Scene Technology | Trousse de revelation comprenant une tetrazine et un cyanoacrylate, procede de co-fumigation d'une tetrazine et d'un cyanoacrylate |
| CA2952188A1 (en) * | 2014-06-20 | 2015-12-23 | Aurigene Discovery Technologies Limited | Substituted indazole compounds as irak4 inhibitors |
| WO2017039318A1 (en) * | 2015-09-01 | 2017-03-09 | Kainos Medicine, Inc. | Benzimidazole derivatives for dna methylation inhibitors |
| US10342868B2 (en) | 2016-01-15 | 2019-07-09 | Augusta University Research Institute, Inc. | Methods and compositions for inhibiting Akt3 |
| CN106749071B (zh) * | 2017-01-10 | 2019-03-01 | 江西师范大学 | 一种芳香类1,2,4,5-四嗪化合物的制备方法 |
| EP3678666B1 (en) * | 2017-09-07 | 2025-07-09 | Augusta University Research Institute, Inc. | Specific akt3 activator and uses thereof |
| CN117887659A (zh) * | 2018-05-01 | 2024-04-16 | 云南济慈再生医学研究院有限公司 | 一种促进靶细胞向神经细胞分化的方法 |
| BR112022022327A2 (pt) * | 2020-05-08 | 2023-01-03 | Georgiamune Llc | Moduladores de akt3 e métodos de uso dos mesmos |
-
2021
- 2021-05-07 CN CN202180046120.3A patent/CN115867562A/zh active Pending
- 2021-05-07 US US17/923,707 patent/US20230183226A1/en active Pending
- 2021-05-07 MX MX2022014022A patent/MX2022014022A/es unknown
- 2021-05-07 EP EP21800844.9A patent/EP4146667A4/en active Pending
- 2021-05-07 BR BR112022022438A patent/BR112022022438A2/pt unknown
- 2021-05-07 WO PCT/US2021/031386 patent/WO2021226519A1/en not_active Ceased
- 2021-05-07 CA CA3182275A patent/CA3182275A1/en active Pending
- 2021-05-07 AU AU2021266786A patent/AU2021266786A1/en active Pending
- 2021-05-07 PH PH1/2022/553032A patent/PH12022553032A1/en unknown
- 2021-05-07 IL IL297599A patent/IL297599A/en unknown
- 2021-05-07 KR KR1020227042290A patent/KR20230025534A/ko active Pending
- 2021-05-07 JP JP2022567836A patent/JP7739334B2/ja active Active
-
2025
- 2025-09-03 JP JP2025145822A patent/JP2026004302A/ja active Pending
- 2025-10-21 IL IL324116A patent/IL324116A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023525757A5 (cg-RX-API-DMAC10.html) | ||
| JP2023524600A5 (cg-RX-API-DMAC10.html) | ||
| Mohanty et al. | Antibacterial activity of Thiazole and its derivatives: A | |
| AU2018358157B2 (en) | Modulators of the integrated stress pathway | |
| CA2672596C (en) | Compositions and methods of using (r)-pramipexole | |
| CZ297907B6 (cs) | Aminothiazolové deriváty a farmaceutické kompozice s jejich obsahem | |
| CA2972014A1 (en) | Fused pyrimidine compounds for the treatment of hiv | |
| JP2024541995A5 (cg-RX-API-DMAC10.html) | ||
| HUP0301213A2 (hu) | Ciklin dependens kinázok amino-tiazol inhibitorai, ezeket tartalmazó gyógyszerkészítmények, előállításuk és alkalmazásuk | |
| IL297612A (en) | Control of an electronic evaporation device | |
| AU2018360850A1 (en) | Modulators of the integrated stress pathway | |
| CA3008747A1 (en) | Novel compounds | |
| JP2024540107A5 (cg-RX-API-DMAC10.html) | ||
| NO20100827L (no) | Glukocorticoid-mimetica, fremgangsmater for fremstilling av dem, farmasoytiske blandinger, og anvendelser derav | |
| JP2017520571A5 (cg-RX-API-DMAC10.html) | ||
| JP2023525756A5 (cg-RX-API-DMAC10.html) | ||
| JP2017532360A5 (cg-RX-API-DMAC10.html) | ||
| KR20090055562A (ko) | 오로라 a 선택적 억제 작용을 갖는 신규한 아미노피리딘 유도체 | |
| NO20034031L (no) | Substituerte pyrazol- og tiazolpyrimidiner | |
| JP2022536901A5 (cg-RX-API-DMAC10.html) | ||
| JP2026004302A (ja) | Akt3モジュレーター | |
| PL348108A1 (en) | Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them | |
| JP2024541994A5 (cg-RX-API-DMAC10.html) | ||
| JP2023554391A5 (cg-RX-API-DMAC10.html) | ||
| EP2211637A4 (en) | METHOD FOR PRODUCING STAINED AND FLAVORED COMPLETE RICE IN A RETORT METHOD |